Rifaximin: Difference between revisions
ClaireLewis (talk | contribs) |
ClaireLewis (talk | contribs) |
||
| Line 18: | Line 18: | ||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | ||
*[[Lactation risk categories|Lactation risk]]: | *[[Lactation risk categories|Lactation risk]]: Infant risk cannot be ruled out | ||
===Renal Dosing=== | ===Renal Dosing=== | ||
*No adjustment | *No adjustment | ||
Revision as of 03:35, 14 July 2016
Administration
- Type: Antibiotic
- Dosage Forms: 200, 550
- Routes of Administration: Oral
- Common Trade Names: Xifaxan
Adult Dosing
- Traveler's diarrhea, E. coli-induced: 200 mg PO tid x3 days
- Hepatic encephalopathy: 550 mg PO bid
- IBS, diarrhea-predominant: 550 mg PO tid x14 days
- May repeat dose up to 2x if recurrent disease
Pediatric Dosing
For > 12 yrs old
- Traveler's diarrhea, E. coli-induced: 200 mg PO tid x3 days
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk cannot be ruled out
Renal Dosing
- No adjustment
Hepatic Dosing
- No adjustment
Contraindications
- Allergy to class/drug
- caution if hepatic impairment (Child-Pugh Class C)
- caution if recent antibiotic-associated colitis
Adverse Reactions
Serious
- superinfection
- C. difficile-assoc. diarrhea
- hypersensitivity reaction
- angioedema
- anaphylaxis
- exfoliative dermatitis
Common
- peripheral edema
- nausea
- dizziness
- fatigue
Comments
See Also
References
<Epocrates, UpToDate>